Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JOY study of Jiuhua hemorrhoid suppository for hemorrhoidal bleeding
ChiCTR1800019613Phase 4Recruiting
- Sponsor
- Affiliated Hospital of Hunan Academy of Traditional Chinese Medicine
- Start
- Dec 2018
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of diosmin in hemorrhoid (2 arms), sponsored by Affiliated Hospital of Hunan Academy of Traditional Chinese Medicine. Primary endpoint: Relief of hemorrhoidal bleeding at Day 7. Started Dec 2018; status: recruiting.
02
Drugs
diosmin
03
Conditions
hemorrhoid
Beyond the preview
Go deeper on ChiCTR1800019613.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800019613.